Cholinergic neuron & Cholinergic Receptors

•Drugs affecting the autonomic nervous system(ANS) are divided into two groups according to the type of neuron involved in mechanism of action.

•The cholinergic drugs, which act on receptors activated by acetylcholine(Ach), Where as adrenergic drugs act on receptors stimulated by epinephrine or norepinephrine.

•The cholinergic drugs act by either stimulating or blocking the receptors of the ANS.

The cholinergic neuron

• The preganglionic fibres terminating in adrenal medulla.

• The postganglionic fibres of parasympathetic division use ACh as a neurotransmitter. The postganglionic sumpayhetic division of sweat glands also uses ACh.

• Ina ddition, cholinergicneurons innervate the muscles of somatic system and play an important role in CNS.

NEUROTRANSMISSION @ CHOLINERGIC NEURON:

• Neurotransmission at cholinergic neurons involves 6 sequential steps :

(1) Synthesis of ACh

(2) Storage of ACh

(3) Release of ACh

(4) Binding of ACh to the receptor

(5) Degradation of ACh in the syneptic cleft

(6) Recycling of Choline

(1) Synthesis of Acetylcholine :

• Choline js transported from extracellular fluid into the cytoplasm of cholinergic neuron by an energy dependent carrier system that co-transport the sodium and can be inhibited by the drug hemicholinium.

• Choline has quaternary nitrogen amd carries a permanant positive charge and thus cannot diffuse through the membrane.

• The uptake of choline is the rate limiting step in ACh synthesis.

• Choline acetyl tranferase catalyzes the reaction of choline with acetyle coenzyme A to form ACh ester in the cytosol.

(2) Storage of Acetylcholine in vessicle :

• ACh is packaged and stored in presynaptic vessicle by an active transport process.

• The mature vessicle contain not only acetylcholine but also ATP and proteoglycan.

• The vessicle contain primary neurotransmitter as well as cotransmitter (ATP) that increase or decrease the effect of the primary neurotransmitter.

(3) Release of Acetylcholine :

• When an action potential arrives at nerve ending, voltage gated calcium channels on the synaptic membrane open, causing an increase in concentration of intracellular Ca++.

• Eleveated Ca level promotes the fusion of synaptic vessicle with cell membrane and release of contents(ACh) into the synaptic space.

(4) Binding of Receptor :

• ACh released from synaptic vessicle diffuse across the synaptic space and binds to the post synaptic receptors of target cells.

• The post-synaptic cholinergic receptors on the surface of effector organs are divided into two classes; muscarinic and nicotinic.

• Binding to a receptor leads to the biological response within the cell. Such as initiation of nerve impulse in postganglionic fibre or activation of specific enzymes in effector cells, as mediated by 2ndry messenger mollecules.

(5) Degradation of Acetylcholine :

• The signal at the post-junctional effector site is rapidly terminated, beacause acetylcholinterase (AChE) cleaves ACh in to Chloine & acetate in the synaptic cleft.

(6) Recycling of Choline :

• Choline may be recaptured by a sodium coupled, high affinity uptake system that transport the mollecule back into the neuron. So that it can be available to be acetylated in to ACh.

Cholinergic Receptors (Cholinoreceptors)

• Two families of chiloceptors are muscarinic and nicotinic recptors, can be distinguished from each other on the basis of their different affinities for agents that mimics the action of ACh.

(1) Muscarinic Receptors

• Muscarinic receptors belongs to the class of G-protein-coupled-receptors( metabotropic receptors).

• These receptors in addition to binding ACh, also recognize muscarine, an alkaloid in certain poisonous mushroom.

• There are 5 types of muscarinic receptors (M1, M2,M3, M4, M5).

(i) Location of muscarinic receptors :

• These receptors are found on the autonomic effector organs such as heart, smooth muscles, brain and exocrine glands.

• M1 receptors are found on gastric parietal cells.

• M2 receptors are found on cardiac muscles & smooth muscles.

• M3 receptors are found on bladder, exocrine glands & smooth muscles.

==>•When muscarimic drugs given in high concentration then they may show some activity at nicotinic receptors also.

(ii) Mechanism of acteylcholine signal transduction:

• Signal can be generated by ACh by different mollecule mechanism on the receptor. For example :

• M1& M3 receptors are activated, the receptor undergoes a conformational change and interacts with a G-protein that activates Phopholipase C. This ultimately leads to production of 2ndry messenger IP3 and DAG.

• IP3 cause hyperpolarization by releasing of Calcium and DAG activates protein kinase C which phosphorylates many protein within the cell.

(iii) Muscarinic agonists :

• Pilocarpine is the non-selective muscarinic receptor used to treat xerostomia and glaucoma.

(2) Nicotinic Receptors :

• These Receptors in addition to binding with ACh, also recognise nicotine but show only a weak affinity for muscarine.

• The nicotinic receptors is composed of 5 subunits, & it function as ligand gated ion channel(ionotropic receptors).

• Nicotinic receptors are located in CNS, adrenal medulla, autonomic gangliaamd nueromuscular junction(NMj) in skeletel muscels.

• Binding of two ACh mollecules elicits a conformational change that allows the entry of sodium ions, resulting in depolarisation of the effector cells.

• Nicotine at low concomtration stimulates the receptor and at high concentration it blocks the receptor.

• Nicotinic receptors at NMj are differ from autonomic ganglia. For example : NMJ receptors are specifically blocked by atracurium and whereas ganglionic receptors are selectively blocked by mecamylamine.

Comments

Autonomic Nervous System Anatomy and Physiology

The Autonomic Nervous System • The Autonomic Nervous System(ANS) along with endocrine system coordinates the regulation amd integeration of body functions. •The ANS largerly independent (autonomous) in that its activities are not under direct conscious control. It is concenred primarily with visceral functions such as cardiac output, blood flow to various organs and digestions, which is necessary for life. • Drugs that produce their primary therpeutic effect by mimicking or altering the functions of ANS are called autonomic drugs. - The autonomic agents act either by stimulating portion of ANS or by blocking the action of autonomic nerves . Nervous System overview : • The N.S is divided into 2 anatomical divisions : The Central Nervous System which is composed of brain & spinal cord and the Peripheral Nervous System . • Peripheral nervous system includes neurons which located outside the brain and spinal cord. • The peripheral nervous syste

AGONIST & ANTAGONIST with types

AGONIST • Agonist is a chemical(drug) that binds to the receptor and activates the receptor to produce biological response. OR • Agonist is a drug that produce effects on endogenous compounds, when it interacts with it’s receptor. => Agonists are of following types: (1) Full agonists (2) Partial agonists (3) Inverse agonists (1) Full Agonists • If a drug binds to a receptor and produce maximal biological response that mimics the response to endogenous ligand is called full agonist. - All full agonists for a receptor population should produce the same E max. For Example : phenylephrine is a full agonist at alpha1-adrenoceptors, because it produce the same E max as the endogenous ligand, norepinephrine. Upon binding with aplha1-adrenoceptors on vascular smooth muscle, both phenylephrine and norepinephrine stablize the receptor in its active state, thereby increasing the Gq activation. Activation of Gq i

Mechanism of absorption of Drugs

Absorption of Drugs • Absorption concerns the process of entry of drug in to systemic circulation from site of administration. •The rate and extent of absorption depend on: -the environment where the drug is absorbed -chemical characteristics of drug -route of administration (which influence bioavailability) • The route of administration other than intravenous may result in partial absorption and lower bioavailability. (A) Mechanism of absorption of drug from GIT • Depending upon their chemical properties , drugs may be absorbed from GI tract by passive diffusion, facilitated diffusion, active transport or endocytosis. (1) Passive diffusion : • In this drug move from area of high concentration to area of lower concentration. - also known as non-ionic diffusion - The driving force for this process is concentration or electrochemical gradient. - P.D does not require carrier, is not saturable, and shows low structural specifity. - The

Elimination of the Drug

Drug Elimination • Drugs must be sufficiently polar to be eliminated from the body. • Removal of drugs from body occur via number of routes; the most important is elimination through kidney in to urine. Renal Elimination of Drug • A drug passes through several process in the kidney before elimination, Glomerular filtration, tubular seceration , and passive tubular reabsorption. (1) Glomerular filteration : • Drugs enter the kidney through renal artries, which divide to form a glomerular capillary plexus. Free drug (not bound to albumin) flows through the capillary bed into bowman’s space as a part of glomerular filterate. > Glomerular filteration rate is normally about 120mL/min. But may decrease sugnificantly in renal disease. > pH and lipid solubility do not influence the passage of drugs into glomerular filterate. > Variation in GFR and protein binding to drugs donot affect this process. > water and polar compounds easily enter in gl

Cholinergic Drugs (direct acting) Part-2

(3) CARBACHOL (Carbamylcholine ) • Carbachol is is an ester of carbamic acid and poor substrate for AChEsterase. It is biotransformed by other esters at very slow rate. • Carbachol has both Muscarinic and Nicotinic actions. Functions (i) Actions : • Carbachol has profound effects on both Cardiovascular system and GI system. • It has ganglion stimulating activity and it may first stimulate and then depress these systems. • It can cause release of epinephrine from adrenal medulla by its nicotinic functions. On Eye : • It cause miosis • It cause spasm of accomodatiom in which the ciliary muscle of the eye remains in a constant state of contraction. • Carbachol is also used to stimulate micturation by contraction of detrusor muscle. (ii) Therapeutic uses : • Carbachol has high potency, receptor non-selectivity and relatively long duration of action. • Carbachol is rarely used. • Carbachol administered ocularly to induce miosis to reduce the intr

PHARMACODYNAMICS & Drug Receptor Interaction

>Pharmacodynamics deals with the biochemical and physiological effect of drug as well as its mechanism of action. OR We can simply define it as, The action of drug on the body. •Most drug exert effects, both beneficial and harmful, by interacting with specialized target macromollecule called receptor. Receptor : it refers to the drug binding site in the cell or on the surface of cell which mediate the action of drug. • There are some drugs which do not require receptors Example = mannitol , anti-helmintic drugs, etc. NATURE OF DRUG RECEPTOR 1. Regulatory protein which mediates the action of endogenous chemical signals. For example : neurotransmitters , harmones and autocoids. 2. Enzymes. For example : dihydrofolic reductase 3. Transport protein. For example : sodium / potassium ATPase pump. 4. Structural protein. For example : tubulin. RECEPTOR REGULATION •Down Regulation : when receptors becom

Cholinergic Drugs (Direct acting) Part-1

Cholinergic Agonists (direct acting) • Cholinergic agonists mimic the effect of acetylcholine by binding directly to cholinoceptors (muscarinic & nicotinic). • These agents are classified into 2 groups; (1) Choline esters : it includes endogenous ACh and synthetic esters of choline. Such as Carbachol & Bethanechol . (2) Naturally occuring Alkaloids : Nicotine & Pilocarpine . • All direct-actings Cholinergic drugs have longer duration of action than Acetylcholine. (1) ACETYLCHOLINE • ACh is the quaternary ammonium compound that cannot penetrates membranes. • It is nuerotransmitter of parasympathetic, somatic nerves & autonomic ganglia. • It lacks the therapeutics importance b/c of multiple actions and its rapid inactivation by the cholinesterases. • ACh has both muscarinic and nicotinic activity. Functions : (a) Decrease in heart rate and cardiac output : • ACh mimics the effects of vagal stimulation on the heart. • If in

Drug clearance & Half Life & Dose

Drug Clearance It refers to the ratio of rate of drug elimination to the concentration of drug in biological fluid(C). CL = rate of elimination / C Rate of elimination • For most of the drugs, elimination is not saturable & rate of drug elimination is directly proportional to concentration. Rate of elimination = CL x C ==> The difference between drug clearance and drug elimination is that : • Clearance is Volume of blood cleared of drug per unit time and Elimination is amount of drug cleared from blood per unit time. Total Body Clearance • The total body systemic clearance , CLtotal is the sum of all clearances from drug metabolising and drug eliminating organs. OR • Dividing the rate of elimination at each organ by concentration of drug presented to it yeilds respective clearance at that organ and sum of these is total body clearance. CLx = rate of elimination x / C

Drug Clearance by Biotranformation

Drug clearance : Once a drug enters into the body, the process of elimination begins. The three major routes of eliminations are: (i) Hepatic metabolism (ii) Biliary elimination (iii) Urinary excreation Excreation is irreversible removal of the drug from the body. It involves BIOTRANSFORMATION & EXCREATION. •> Metabolism results in products with increase polarity, which allows the drug to be eliminated. •> Clearance(CL) estimates the vomume of blood from which the drug is cleared per unit of time. CL = 0.693 x V d / t 1/2 - W here T 1/2 is the elimination half life, Vd is apparent volume of distribution and 0.693 is natural log. BIOTRANSFORMATION • The general principle of biotransformation is the metabolic conversion of drug mollecule to more water soluble metabolites that are more readily excreated. - In many cases, metabolism of drug results in its conversion to compounds that have little or no pharmacological activity

Search This Blog